Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Lesch-Nyhan syndrome is a rare genetic disorder caused by mutations in the HPRT1 gene, leading to a deficiency in the enzyme hypoxanthine-guanine phosphoribosyltransferase. While the definitive diagnosis relies on genetic testing, blood tests play a crucial role in monitoring the biochemical consequences and guiding treatment of this condition.
This test measures uric acid levels in the blood, which are characteristically elevated in Lesch-Nyhan syndrome due to the genetic defect causing overproduction of uric acid. Regular monitoring helps assess treatment response and prevent complications including gout, kidney stones, and bladder stones that commonly occur with this condition.
Although there isn't a single blood test to diagnose Lesch-Nyhan syndrome itself, blood testing is fundamental for monitoring the characteristic overproduction of uric acid that occurs with this genetic disorder. These tests help healthcare providers track treatment effectiveness and prevent complications such as gout, kidney stones, and bladder stones.
The enzyme deficiency in Lesch-Nyhan syndrome disrupts normal purine metabolism, leading to excessive uric acid production. Regular monitoring of serum uric acid levels allows healthcare providers to adjust medications like allopurinol, which can help reduce uric acid production and prevent the painful complications associated with uric acid crystal formation in joints and kidneys.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment. Lesch-Nyhan syndrome requires specialized medical care and genetic counseling.